SG83135A1 - Di-or triaza-spiro(4,5)decane derivatives - Google Patents

Di-or triaza-spiro(4,5)decane derivatives

Info

Publication number
SG83135A1
SG83135A1 SG9902947A SG1999002947A SG83135A1 SG 83135 A1 SG83135 A1 SG 83135A1 SG 9902947 A SG9902947 A SG 9902947A SG 1999002947 A SG1999002947 A SG 1999002947A SG 83135 A1 SG83135 A1 SG 83135A1
Authority
SG
Singapore
Prior art keywords
triaza
spiro
decane derivatives
decane
derivatives
Prior art date
Application number
SG9902947A
Other languages
English (en)
Inventor
Geo Adam
Andrea Cesura
Francois Jenck
Sabine Kolczewski
Stephan Roever
Juergen Wichmann
Original Assignee
Hoffmann La Roche
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Hoffmann La Roche filed Critical Hoffmann La Roche
Publication of SG83135A1 publication Critical patent/SG83135A1/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
    • C07D471/10—Spiro-condensed systems
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/04—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/02—Drugs for disorders of the nervous system for peripheral neuropathies
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/08—Antiepileptics; Anticonvulsants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/22—Anxiolytics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/24—Antidepressants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
    • A61P25/36—Opioid-abuse
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/04—Anorexiants; Antiobesity agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/12—Drugs for disorders of the metabolism for electrolyte homeostasis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D513/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for in groups C07D463/00, C07D477/00 or C07D499/00 - C07D507/00
    • C07D513/02—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for in groups C07D463/00, C07D477/00 or C07D499/00 - C07D507/00 in which the condensed system contains two hetero rings
    • C07D513/10—Spiro-condensed systems

Landscapes

  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Biomedical Technology (AREA)
  • Neurosurgery (AREA)
  • Neurology (AREA)
  • Psychiatry (AREA)
  • Pain & Pain Management (AREA)
  • Addiction (AREA)
  • Obesity (AREA)
  • Hematology (AREA)
  • Diabetes (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Child & Adolescent Psychology (AREA)
  • Hospice & Palliative Care (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Non-Silver Salt Photosensitive Materials And Non-Silver Salt Photography (AREA)
  • Photoreceptors In Electrophotography (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
SG9902947A 1998-06-12 1999-06-09 Di-or triaza-spiro(4,5)decane derivatives SG83135A1 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
EP98110803 1998-06-12

Publications (1)

Publication Number Publication Date
SG83135A1 true SG83135A1 (en) 2001-09-18

Family

ID=8232113

Family Applications (1)

Application Number Title Priority Date Filing Date
SG9902947A SG83135A1 (en) 1998-06-12 1999-06-09 Di-or triaza-spiro(4,5)decane derivatives

Country Status (30)

Country Link
US (1) US6642247B2 (cs)
EP (1) EP0963985B1 (cs)
JP (1) JP3369123B2 (cs)
KR (1) KR100393311B1 (cs)
CN (2) CN1229377C (cs)
AR (1) AR019860A1 (cs)
AT (1) ATE234302T1 (cs)
AU (1) AU752835B2 (cs)
BR (1) BR9902653A (cs)
CA (1) CA2274201C (cs)
CO (1) CO5040061A1 (cs)
CZ (1) CZ291323B6 (cs)
DE (1) DE69905798T2 (cs)
DK (1) DK0963985T3 (cs)
ES (1) ES2194402T3 (cs)
HR (1) HRP990187A2 (cs)
HU (1) HUP9901910A3 (cs)
ID (1) ID23306A (cs)
IL (1) IL130375A0 (cs)
MA (1) MA26645A1 (cs)
NO (1) NO312591B1 (cs)
NZ (1) NZ336226A (cs)
PE (1) PE20000540A1 (cs)
PL (1) PL333693A1 (cs)
PT (1) PT963985E (cs)
SG (1) SG83135A1 (cs)
TR (1) TR199901380A2 (cs)
TW (1) TW434241B (cs)
YU (1) YU26799A (cs)
ZA (2) ZA993853B (cs)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0997464B1 (en) * 1998-10-23 2005-02-16 Pfizer Inc. 1,3,8-Triazaspiro[4,5] decanone compounds as orl1-receptor agonists
EP1491212B1 (en) 2002-03-29 2012-08-08 Mitsubishi Tanabe Pharma Corporation Remedy for sleep disturbance
DE102004014296A1 (de) * 2004-03-22 2005-10-06 Grünenthal GmbH Substituierte 1,4,8-Triazaspiro[4.5]decan-2-on-Verbindingen
KR100662191B1 (ko) 2004-12-23 2006-12-27 엘지이노텍 주식회사 질화물 반도체 발광소자 및 그 제조방법
KR101165504B1 (ko) 2007-03-01 2012-07-13 미쓰비시 타나베 파마 코퍼레이션 벤조이미다졸 화합물 및 그의 의약 용도
TW201016675A (en) 2008-09-16 2010-05-01 Mitsubishi Tanabe Pharma Corp Crystalline benzoimidazole compound and salt thereof
CN109503582A (zh) * 2018-12-17 2019-03-22 上海合全药物研发有限公司 顺式螺[哌啶并-4,1＇-吡咯并[3,4-c]吡咯]-1-甲酸叔丁酯的合成方法
EP4137496A4 (en) * 2020-05-12 2024-08-21 Beijing Greatway Pharmaceutical Technology Co., Ltd. COMPOUND FOR ADJUSTING NMDA RECEPTOR ACTIVITY, ASSOCIATED PHARMACEUTICAL COMPOSITION AND USE
KR20220022988A (ko) 2020-08-20 2022-03-02 제트스타 주식회사 트랙터용 써레

Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS63208844A (ja) * 1987-02-26 1988-08-30 Konica Corp 有機着色物質の光褪色防止方法

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5221675A (en) * 1989-12-15 1993-06-22 Abbott Laboratories Aza-spirocyclic compounds that enhance cholinergic neurotransmission
US5534520A (en) * 1990-04-10 1996-07-09 Fisher; Abraham Spiro compounds containing five-membered rings
CA2226058C (en) * 1997-01-30 2008-01-29 F. Hoffmann-La Roche Ag 8-substituted-1,3,8-triaza-spiro[4.5]decan-4-one derivatives

Patent Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS63208844A (ja) * 1987-02-26 1988-08-30 Konica Corp 有機着色物質の光褪色防止方法

Also Published As

Publication number Publication date
HU9901910D0 (en) 1999-08-30
DE69905798T2 (de) 2004-02-12
AU3498699A (en) 1999-12-23
AR019860A1 (es) 2002-03-20
JP3369123B2 (ja) 2003-01-20
PE20000540A1 (es) 2000-07-15
HUP9901910A3 (en) 2001-11-28
US6642247B2 (en) 2003-11-04
ZA993901B (en) 1999-12-13
DK0963985T3 (da) 2003-06-23
CA2274201C (en) 2010-02-09
CO5040061A1 (es) 2001-05-29
JP2000026466A (ja) 2000-01-25
IL130375A0 (en) 2000-06-01
AU752835B2 (en) 2002-10-03
DE69905798D1 (de) 2003-04-17
ATE234302T1 (de) 2003-03-15
CN1244528A (zh) 2000-02-16
ZA993853B (en) 1999-12-13
NO992876L (no) 1999-12-13
BR9902653A (pt) 2000-05-02
CZ203999A3 (cs) 2000-03-15
CN1229377C (zh) 2005-11-30
NO312591B1 (no) 2002-06-03
CN1110497C (zh) 2003-06-04
MA26645A1 (fr) 2004-12-20
CN1242367A (zh) 2000-01-26
NO992876D0 (no) 1999-06-11
HUP9901910A2 (hu) 2000-04-28
YU26799A (sh) 2002-03-18
PL333693A1 (en) 1999-12-20
CA2274201A1 (en) 1999-12-12
ID23306A (id) 2000-04-05
CZ291323B6 (cs) 2003-02-12
ES2194402T3 (es) 2003-11-16
EP0963985B1 (en) 2003-03-12
US20030176701A1 (en) 2003-09-18
KR20000006135A (ko) 2000-01-25
PT963985E (pt) 2003-06-30
EP0963985A2 (en) 1999-12-15
EP0963985A3 (en) 2001-01-24
TR199901380A3 (tr) 2001-01-22
NZ336226A (en) 2000-10-27
HRP990187A2 (en) 2000-02-29
KR100393311B1 (ko) 2003-08-02
TR199901380A2 (xx) 2001-01-22
TW434241B (en) 2001-05-16

Similar Documents

Publication Publication Date Title
DE69941083D1 (en) 12,13-cyclopropan-epothilonderivate
PL349504A1 (en) 1,2-annelated quinoline derivatives
ZA99254B (en) Benzosulfone derivatives.
IL127566A0 (en) Substituted 6,5-hetero- bicyclic derivatives
SI0925298T1 (en) Substituted 6,6-hetero-bicyclic derivatives
EP1120407A4 (en) CYSTEINE DERIVATIVES
SI0856514T1 (en) 8-substituted-1,3,8-triazaspiro(4.5)decan-4-on derivatives
SI0921125T1 (en) 1,3,8-Triazaspiro(4,5)decan-4-on derivatives
ZA9811940B (en) Novel erythromycin derivatives.
IL134220A0 (en) 6,9-bridged erythromycin derivatives
HU9802807D0 (en) 1,3,8-triazo-spiro[4,5]decan-4-on derivatives
IL134996A0 (en) 6,11-bridged erythromycin derivatives
IL143095A0 (en) 3,3-biarylpiperidine and 2,2-biarylmorpholine derivatives
IL126624A0 (en) 3-descladinose-2, 3-anhydroerythromycin derivatives
ZA991550B (en) Cyclohexanediole derivatives.
SG83135A1 (en) Di-or triaza-spiro(4,5)decane derivatives
AU2964899A (en) 2,4-dioxo-5-arylidenimino-1,3-pyrimidines
AU6126596A (en) 1,3,8-triaza- and 3,8-diaza-1-oxaspiro(4,5)decane derivatives
HU9700609D0 (en) 1,25-dihydroxy-12,22,23-trisdehydro-cholecalciferol derivatives
GB9810998D0 (en) Antitumour 1,5-diazaanthraquinones
GB2350361B (en) 3,4,5-tricyanophenyl derivatives
AU4263999A (en) Substituted 1,3-diaza-2-(thi)oxo-cycloalkanes
ZA989848B (en) 6,11-bridged erythromycin derivatives
SI1015467T1 (en) 6,9-bridged erythromycin derivatives
SI1027361T1 (en) 6,11-bridged erythromycin derivatives